The MOTION randomized controlled trial for treatment of lumbar spinal stenosis using the percutaneous mild® procedure: 5-year results

Keyphrases

• Randomized Controlled Trial 100%
• Treatment Group 100%
• 5-year Outcomes 100%
• Lumbar Spinal Stenosis 100%
• No Significant Difference 66%
• Treatment Duration 66%
• Young Patients 66%
• 3-year Follow-up 66%
• Lumbar Spine 66%
• Spinal Intervention 66%
• Oswestry Disability Index 66%
• Numeric Pain Rating Scale 66%
• Zurich Claudication Questionnaire 66%
• Adverse Events 33%
• Spinal Decompression 33%
• Older Patients 33%
• Symptom Severity 33%
• Multicenter Randomized Controlled Trial 33%
• Extended Follow-up 33%
• Patient Outcomes 33%
• Patient Health Questionnaire 33%
• Intent-to-treat 33%
• Objective Measurement 33%
• Continued Use 33%
• 5-year Follow-up 33%
• Physical Function 33%
• Neurogenic Claudication 33%
• Severity Functions 33%
• Stryker 33%
• Subjective Outcome 33%
• Tolerance Test 33%
• Ligamentum Flavum Hypertrophy 33%
• Unilateral Laminotomy for Bilateral Decompression 33%
• Walking Time 33%
• Prospective multicenter 33%
• Related Adverse Events 33%
• Portage 33%
• Conventional Medical Management 33%
• Ongoing Symptoms 33%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Claudication 100%
• Lumbar Spinal Stenosis 100%
• Treatment Group 100%
• Numeric Rating Scale 66%
• Lumbar Spine 66%
• Oswestry Disability Index 66%
• Spine Intervention 66%
• Adverse Event 66%
• Spinal Cord Decompression 33%
• Intention-to-Treat Analysis 33%
• Ligamentum flavum 33%
• Long-Term Outcome 33%

Nursing and Health Professions

• Claudication 100%
• Lumbar Spinal Stenosis 100%
• Treatment Group 100%
• Adverse Event 66%
• Numeric Rating Scale 66%
• Oswestry Disability Index 66%
• Intention to Treat Analysis 33%
• Disease Management 33%
• Treatment Outcome 33%
• Physical Function 33%
• Spinal Cord Decompression 33%